Acrux CEO and managing director Michael Kotsanis said, “We are very pleased to receive FDA approval for another ANDA product which has been developed in house by the Acrux R&D team." …
Acrux says US FDA approves its nitroglycerin ointment for moderate to severe pain
December 4, 2024 Latest NewsBioPharma
Latest Video
New Stories
-
New data reveals deep inequities as Sanofi rolls out trust-building initiative
September 17, 2025 - - Latest News -
Ipsen appoints Dagmar Tschoep as general manager for Australia and New Zealand
September 16, 2025 - - Latest News -
Merck welcomes new director of market access, government affairs and communications
September 16, 2025 - - Latest News -
New mental health service takes aim at the silent struggle of undiagnosed ADHD
September 16, 2025 - - Latest News -
Adelaide to host DHL’s next-generation transport and warehousing facility
September 16, 2025 - - Latest News -
CSL partners with VarmX on first-in-class coagulation treatment
September 16, 2025 - - Latest News -
If this makes you uncomfortable, it should, because it is the only correct response
September 16, 2025 - - Latest News